Author

Ruth Kulicke

Celsius Therapeutics (United States)ORCID 0009-0008-6655-1450Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Gromoslaw Aleksander SmoleniD· 3 shared Nicolas StranskyiD· 3 shared Andre Luis MoreiraiD· 2 shared Anna H. YeatoniD· 2 shared Aristotelis TsirigosiD· 2 shared Fred P. DavisiD· 2 shared Harvey Ira PassiD· 2 shared Kwok‐Kin WongiD· 2 shared

Activity by Year

2023-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Gromoslaw Aleksander SmolenORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 2, 2026

Single-cell trajectories in metastatic urothelial carcinoma reveal tumor-immune reprogramming and macrophage-driven resistance to PD-(L)1 blockade

Ronan Flippot, Amélie Roehrig, Julien Vibert…·Yohann Loriot

This study uses single-cell RNA sequencing to analyze metastatic urothelial carcinoma and identifies macrophage-driven resistance to PD-(L)1 blockade as a key mechanism.

DOI 10.64898/2026.03.31.715549

humanscRNA-seq

𝕏 PostBluesky

BioinformaticsNature CommunicationsPeer-reviewedNov 8, 2023

Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma

Igor Dolgalev, Hua Zhou, Nina Murrell…·Aristotelis Tsirigos

This study identifies inflammation in tumor-adjacent lung tissue as a predictor of clinical outcome in lung adenocarcinoma using multi-omic analysis of 143 stage I cases.

37 citationstop 4%

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 15, 2023

Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growth

Ali Rashidfarrokhi, Ray Pillai, Hao Yuan…·Thales Y. Papagiannakopoulos

This study identifies a LKB1-LIF signaling axis in tumors that promotes immune evasion by reprogramming myeloid cells, and shows that inhibiting LIF signaling reduces tumor growth.

5 citations

mousebulk RNA-seq

𝕏 PostBluesky